Tackling cardiovascular disease in the Asia–Pacific region: a new Lancet Commission

2025

Authors

Lam, C.S.P., Cader, F.A., Chew, N.W.S., Chow, C.K., Grey, C., Guo, Y., Nelson, A.J., Rolleston, A., Sawano, M., Tan, K.C.B., Tromp, J., Yan, L.L., Nicholls, S.J.

Abstract

The Asia–Pacific region has a high global burden of cardiovascular disease.1 The region, home to more than 60% of the world's population, spans the vast and diverse geographies from Oceania through east, central, southeast, and south Asia and includes the world's most populous nations and many of its most rapidly ageing societies.2 Sociocultural, economic, and health system diversity also characterise this region. While cardiovascular disease remains the leading cause of death worldwide,3 its impact is profound in the Asia–Pacific region with crude cardiovascular mortality projected to almost double by 2050 in Asia.4 Addressing cardiovascular disease in this region is not only a local necessity, but also a global imperative.

Publication Link

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01494-1/abstract